Q3 2025 Holdings
Filed 2025-11-10 | 9 holdings | $212.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lenz Therapeutics, Inc.(LENZ) | Common Stock | 52635N103 | $123.8M | 2,656,888 | 58.3% |
| Monte Rosa Therapeutics, Inc.(GLUE) | Common Stock | 61225M102 | $41.9M | 5,652,922 | 19.7% |
| Jade Biosciences, Inc.(JBIO) | Common Stock | 008064206 | $13.2M | 1,525,820 | 6.2% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $9.6M | 148,831 | 4.5% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $7.9M | 2,007,704 | 3.7% |
| Contineum Therapeutics, Inc.(CTNM) | Common Stock | 21217B100 | $6.4M | 542,628 | 3.0% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $4.7M | 2,646,657 | 2.2% |
| Tempest Therapeutics, Inc.(OVASUSD) | Common Stock | 87978U108 | $2.8M | 269,772 | 1.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $2.3M | 506,821 | 1.1% |